Global Genetic Testing Market Forecasts upto 2024

  • 98
    Pages

  • 22
    Tables

  • 37
    Charts

  • 4 / 0
    Regions/ Countries

  • 12
    Companies

  • 10
    Enquiry Hours

[98 Report Pages] This market research report includes a detailed segmentation of the global In Vitro Fertilization market by product (Reagents and Instruments), by cycle type (Fresh IVF Cycles, Thawed IVF Cycles, and Donor IVF Cycles), end-users (Hospitals and Research Laboratories, Fertility and Surgical Centers, and Cryobanks), and by region (North America, EMEA, APAC, and RoW). The market research report identifies Thermo Fisher Scientific Inc., Vitrolife, Cook Medical Inc., Cooper Companies (CopperSurgical Inc.), Irvine Scientific, Genea Limited, OvaScience Inc., Hunter Scientific, EMD Sereno Inc., and ESCO Micro Pte Ltd. as the major vendors operating in the global In Vitro Fertilization market.

Overview of the Global In Vitro Fertilization Market

Infoholic’s market research report predicts that the global In Vitro Fertilization market is expected to grow at a CAGR of 11.2% during the forecast period 2018–2024.

According to the In Vitro Fertilization market industry analysis, Europe accounts for the largest share, followed by North America, Asia Pacific, and Rest of the World. Increasing demand for assisted reproductive technology procedures and smooth implementation of advanced technology makes Europe a dominant shareholder in the market. Whereas, Asia Pacific is the fastest growing market due to increasing fertility tourism, upsurge in awareness, and acceptance of the technology.

In Vitro Fertilization Market Competitive Analysis and Key Vendors

There is an increase in acquisition, collaboration between IVF-related companies, and launching of new IVF products due to the favorable environment for IVF across the globe. For instance, in August 2018, Ferring Pharmaceuticals and Celmatix announced a collaboration, and the primary goal was to uncover new insights into ovarian biology and to accelerate the development of personalized interventions in women health and reproductive medicine. In August 2018, Thomson Medical announced to extend IVF services to China, in collaboration with assisted reproduction specialist IVI-RMA.

The In Vitro Fertilization market is driven by increasing awareness among the public about fertility and accessible treatment options, delayed pregnancies, reducing fertility rates, and initiation from the government to promote IVF treatment. However, high treatment cost, ethical concerns related to IVF, and low success rate of the procedure may slow down the growth of the In Vitro Fertilization market.

Some of the key vendors in the In Vitro Fertilization market are:

  • Thermo Fisher Scientific, Inc.
  • Vitrolife
  • Cook Medical Inc.
  • Cooper Companies (CopperSurgical Inc.)
  • Irvine Scientific

Other prominent vendors are Genea Limited, OvaScience Inc., Hunter Scientific, EMD Sereno, Inc., and ESCO Micro Pte Ltd.

In Vitro Fertilization Market by Product Type

  • Reagents
  • Instruments

Reagents include embryo culture media, cryopreservation media, sperm processing media, and ovum processing media. Instruments comprise imaging system, sperm separation system, ovum aspiration pump, micromanipulator system, incubators, cryosystems, and others.

In 2017, Instruments segment occupied a significant market share and is expected to grow at a high CAGR during the forecast period.

In Vitro Fertilization Market by Cycle Type

  • Fresh IVF Cycles
  • Thawed IVF Cycles
  • Donor IVF Cycles

In 2017, the Fresh IVF Cycles segment occupied a significant market share and is expected to grow at a high CAGR during the forecast period due to the increased success rate in the first attempt.

In Vitro Fertilization Market by End-users

  • Hospitals and Research Laboratories
  • Fertility and Surgical Centers
  • Cryobanks

In 2017, the Fertility and Surgical Centers segment occupied a significant market share in 2017 and is expected to remain the same for the next five years due to the availability of technologically advanced IVF treatment and a broad range of fertility treatment with reimbursement facilities.

In Vitro Fertilization Market Benefits

The report provides detailed information about the usage and adoption of In Vitro Fertilization market in therapeutic verticals and regions. Additionally, key stakeholders can find out the major trends, drivers, investments, vertical player’s initiatives, government and company initiatives toward the adoption of in vitro fertilization in the upcoming years in the market. Moreover, the report provides details about the major challenges that are going to have an impact on market growth. Furthermore, the report gives complete details about the business opportunities to key stakeholders to expand their business and capture revenues in the specific verticals. The report will help companies interested or established in this market to analyze the various aspects of this domain before investing or expanding their business in the In Vitro Fertilization market.

1 INDUSTRY OUTLOOK  
1.1        Industry overview
1.2        Total addressable market
1.3        Industry Trends

2 Report Outline 
2.1        Report Scope
2.2        Report Summary
2.3        Research Methodology
2.4        Report Assumptions

3 Market Snapshot 
3.1        Market Definition – Infoholic Research
3.2        Advantages of genetic testing
3.3        Disadvantage of genetic testing
3.4        Segmented Addressable Market (SAM)
3.5        Trends of the genetic testing market
3.6        Related Markets
3.6.1     Point-Of-Care Diagnostics
3.6.2     Liquid biopsy
3.6.3     Transplantation diagnostics
3.6.4     Cell-free DNA testing

4 Market Outlook 
4.1        Funding Scenario
4.2        Market segmentation
4.3        PEST Analysis
4.4        Porter 5(Five) Forces

5 Market Characteristics 
5.1        DRO – Global Genetic Testing Market Dynamics
5.1.1     Drivers
5.1.1.1 Increasing incidence of disease across the globe 
5.1.1.2 Upsurge in the demand for personalized medicine 
5.1.1.3 Growing emphasis on early disease detection 
5.1.2     Opportunities
5.1.2.1 Upsurge in healthcare spending and growing healthcare awareness in emerging countries 
5.1.2.2 Increase in collaborations 
5.1.3     Restraints
5.1.3.1 High test cost
5.1.3.2 Ethical issues related to genetic testing 
5.2        DRO – Impact Analysis
5.3        Key Stakeholders

6 Test Type: Market Size and Analysis 
6.1        Overview
6.2        Diagnostic testing
6.3        Prenatal and newborn testing
6.4        Predictive and presymptomatic screening
6.5        Others

7 Regions: Market Size and Analysis 
7.1        Overview
7.2        North America
7.3        Europe
7.4        Asia Pacific
7.5        Rest of the World

8 Competitive Landscape 
8.1        Overview

9 Vendor Profiles 
9.1        Qiagen N.V.
9.1.1     Overview
9.1.2     Geographic Presence
9.1.3     Business Focus
9.1.4     SWOT Analysis
9.1.5     Business Strategies
9.2        F. Hoffmann-La Roche Ltd
9.2.1     Overview
9.2.2     Business Units
9.2.3     Geographic Presence
9.2.4     Business Focus
9.2.5     SWOT Analysis
9.2.6     Business Strategies
9.3        ABBOTT LABORATORIES
9.3.1     Overview
9.3.2     Business Unit
9.3.3     Geographic Presence
9.3.4     Business Focus
9.3.5     SWOT Analysis
9.3.6     Business Strategy
9.4        Illumina, Inc.
9.4.1     Overview
9.4.2     Business Units
9.4.3     Geographic Presence
9.4.4     Business Focus
9.4.5     SWOT Analysis
9.4.6     Business Strategy
9.5        Quest Diagnostics
9.5.1     Overview
9.5.2     Business Units
9.5.3     Business Focus
9.5.4     SWOT Analysis
9.5.5     Business Strategy

10 Companies to Watch For 
10.1     Natera, Inc.
10.1.1  Overview
10.2     Myriad Genetics
10.2.1  Overview
10.3     Bio-Rad Laboratories
10.3.1  Overview
10.3.2  Bio-Rad laboratories: Recent Developments
10.4     bioMerieux S.A.
10.4.1  Overview
10.4.2  BioMerieux S.A.: Recent Developments
10.5     Luminex Corporation
10.5.1  Overview
10.5.2  Luminex Corporation: Recent Developments
10.6     Cepheid (Danaher Corporation)
10.6.1  Overview
10.6.2  Cepheid (Danaher Corporation): Recent Developments
10.7     Laboratory Corporation of America Holdings
10.7.1  Overview
10.7.2  Laboratory Corporation of America Holdings: Recent Developments
11 Annexure 
11.1     Abbreviations

Infoholic research works on a holistic 360° approach in order to deliver high quality, validated and reliable information in our market reports. The Market estimation and forecasting involves following steps:

  • Data Collation (Primary & Secondary)
  • In-house Estimation (Based on proprietary data bases and Models)
  • Market Triangulation
  • Forecasting

infoholic Research Methodology

Market related information is congregated from both primary and secondary sources.

Primary sources involved participants from all global stakeholders such as Solution providers, service providers, Industry associations, thought leaders etc. across levels such as CXOs, VPs and managers. Plus, our in-house industry experts having decades of industry experience contribute their consulting and advisory services.

Secondary sources include public sources such as regulatory frameworks, government IT spending, government demographic indicators, industry association statistics, and company publications along with paid sources such as Factiva, OneSource, Bloomberg among others.